New prostate cancer radiation: just 3 doses could be safer
NCT ID NCT06914544
First seen May 06, 2026 · Last updated Jun 22, 2026 · Updated 11 times
Summary
This study tests a new radiation approach for men with early-stage prostate cancer. Instead of the usual 5 sessions, it uses only 3 high-dose treatments. The goal is to see if this shorter course causes fewer side effects while still controlling the cancer. About 175 men will take part across multiple centers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CyberKnife Centrum Mitteldeutschland
RECRUITINGErfurt, Thuringia, 99089, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
European Radiosurgery Center Munich
RECRUITINGMunich, Hesse, 81377, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Saphir Radiosurgery Center Frankfurt am Main
RECRUITINGFrankfurt am Main, Hesse, 60528, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Saphir Radiosurgery Center Norther Germany
ACTIVE_NOT_RECRUITINGKiel, Schleswig-Holstein, 24105, Germany
-
University Hospital Frankfurt
SUSPENDEDFrankfurt am Main, Hesse, 60528, Germany
-
University Medical Center Schleswig-Holstein
RECRUITINGKiel, Schleswig-Holstein, 24105, Germany
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Radiation therapy (hypofractionated radiosurgery)
What this could lead to
If successful, this could offer a shorter, more convenient radiation treatment for prostate cancer with fewer long-term side effects.
What could go wrong
This is a mid-stage trial with only 175 participants, so results may not apply to all patients. There is still a risk of urinary or bowel side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.